GENE ONLINE|News &
Could This Anti-Sperm Immunocontraception Work As a Novel Female Birth Control?
Despite the availability of effective and inexpensive hormonal contraceptives, many women risk unintended pregnancies because of medical contraindications, or serious unpleasant or unbearable side-effects associated with the use of exogenous hormones.
A team of researchers from the University of North Carolina at Chapel Hill has engineered and tested the potency of highly multivalent monoclonal antibodies for non-hormonal contraception.
A team of researchers from the University of North Carolina at Chapel Hill has engineered and tested the potency of highly multivalent monoclonal antibodies for non-hormonal contraception.
GO Prime with only $1.49 now
LATEST
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
